The clean beat on both EPS and revenue, combined with the top-end FY guidance print and a raised dividend, is a clear positive catalyst. The transition-period guidance of $1.80-$1.90 suggests management's confidence in continued synergy capture and operational momentum. Traders should watch for potential upward estimate revisions from the sell-side following this release. The significant net debt reduction ($1.369B in Q4) also strengthens the balance sheet and supports the deleveraging narrative.
Price Chart
Executive Summary
Amcor reported Q4 FY2026 adjusted diluted EPS of $1.23, a 3.2% beat vs. the $1.19 consensus, on revenue of $6.398B (above $6.08B consensus). Full-year adjusted EPS of $4.02 came in at the top end of the prior guidance range ($3.98-$4.03). The company initiated a transition-period (6-month) adjusted EPS outlook of $1.80-$1.90, implying continued strong earnings momentum. The Berry acquisition continues to drive synergy realization ($100M in Q4 alone) and margin expansion, with adjusted EBIT margins up 110bps YoY to 13.1% for the quarter. Net debt was reduced by $374M sequentially to $12.897B, and free cash flow of $1.396B in Q4 was strong. The dividend was increased to $0.65/share from $0.6375. This is a clean beat on both EPS and revenue with raised capital return, supporting a bullish read-through for the stock.
Key Financial Metrics
Key Facts
- Q4 FY2026 adjusted diluted EPS of $1.23 beat consensus of $1.19 by 3.2%
- Q4 revenue of $6.398B exceeded the $6.08B consensus estimate
- Full-year FY2026 adjusted EPS of $4.02 was at the top end of the $3.98-$4.03 guidance range
- Transition period (6-month) adjusted EPS guidance initiated at $1.80-$1.90
- Q4 Berry acquisition synergies of ~$100M; full-year synergies of ~$240M
- Net debt reduced to $12.897B from $14.266B at Q3 end, a $1.369B reduction
- Quarterly dividend increased to $0.65/share from $0.6375
- Q4 adjusted EBIT margin expanded to 13.1% from 12.0% a year ago
- Organic sales declined ~1% in Q4, with volumes up ~0.5% but price/mix down ~1%
Financial Impact
Q4 adjusted EPS beat consensus by $0.04 (+3.2%); revenue beat by ~$318M (+5.2%). Full-year adjusted EPS of $4.02 at top end of guidance. Transition period guidance of $1.80-$1.90 implies continued strong earnings.
Risk Factors
- Organic sales declined ~1% in Q4, with volumes only up ~0.5% and price/mix negative
- Elevated net debt of $12.897B (though rapidly declining) remains a financial risk
- Guidance for the transition period does not factor in potential portfolio optimization actions, creating uncertainty
- Ongoing geopolitical risks (Middle East conflict) cited as a source of uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001748790-26-000020 |
| Document: amcr-20260812.htm | 0001748790-26-000020 |
| Document: 0001748790-26-000020-index-headers.html | 0001748790-26-000020 |
| Document: 0001748790-26-000020-index.html | 0001748790-26-000020 |
| Document: 0001748790-26-000020.txt | 0001748790-26-000020 |
| 8-K Data (Synthetic) | 0001748790-26-000020 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | DEFA14A | $41.72 | awaiting T+20 | — | $46.19 (+10.71%) |
Sep 29, 2026 28d ago | DEFA14A | $42.46 | awaiting T+20 | — | $46.19 (+8.78%) |
Sep 29, 2026 28d ago | DEF 14A | $42.46 | awaiting T+20 | — | $46.19 (+8.78%) |
Aug 12, 2026 10w ago | 8-K | $46.56 $43.00 | ▼ −7.65% | ▼ −5.75% | $46.19 (−0.79%) |
Jun 15, 2026 19w ago | 8-K | $41.11 $42.43 | ▲ +3.21% | ▲ +3.96% | $46.19 (+12.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers